Australia's most trusted
source of pharma news
Tuesday, 21 April 2026
Tuesday, 21 April 2026
Subscribe
Login
Meet the most profitable pharma
Despite ranking only fourth in revenue, this company has taken industry's Most Profitable Pharma crown with the highest net income, but the runner-up with an 83 per cent gross margin was branded the standout.
Gilead builds a new revenue play
With half its revenue coming from a single product, this company is spending big to diversify its earnings
TODAY
PBS rules preventing best practice
PBAC-imposed restrictions on PBS-listed drugs are preventing clinicians from prescribing the best treatment for their patients
TODAY
Jobs go in company streamlining
This company is the latest to streamline its operations with an undisclosed number of job losses
20 April
Drugs jostle for May PBS listing
After two big months for PBS listings, May is shaping up to be much quieter with only seven drugs in the final stage before listing
20 April
Leaders pitch for MA Board role
Nine leaders are hoping to join the Medicines Australia Board with nominees pitching their case to fill four vacancies
17 April
Bosses crack the $40M Club
A handful of pharma company leaders have cracked a new milestone with compensation packages north of AU$40M
17 April
Latest Jobs
Assistant AccoutantAssociate Marketing Manager - OTCInventory Team SupervisorSenior Medical Science LiaisonPharmaceutical Sales RepresentativeQA SpecialistSenior Regulatory Affairs AssociateInventory Analyst28 more...
Pharma in Focus Jobs
Marketing & Communications (4)
- Associate Marketing Manager - OTC - Sydney
- Senior Data & Insights Analyst - Melbourne
- Data & Insights Analyst - Melbourne
- Senior Medical Communications Specialist - Sydney
Sales & Customer Relations (14)
- Pharmaceutical Sales Representative - Sydney
- Account Manager - Sydney
- Senior Territory Manager - Melbourne
- Customer Service Representative - East Ryde
- Customer Service Lead - Frenchs Forest
- Customer Service Representative - St Leonards
- Customer Service Specialist - Frenchs Forest
- Hospital Specialist Representative - Melbourne
- Commercial Analytics & SFE Specialist - Sydney
- Pharmaceutical Sales Representative - Sunshine Coast
- Customer Service Representative - Canning Vale
- Account Manager - Melbourne
- Accountant - Macquarie Park
- Customer Service Representative - Belrose
Clinical & Medical, R&D (9)
- Senior Medical Science Liaison - Melbourne
- Clinical Trial Start Up Specialist - Melbourne
- Clinical Project Manager - Oncology - Sydney, NSW
- Clinical Trials Investigator - Melbourne
- Senior Manager, Clinical Operations (Japan) - Tokyo, Japan
- Medical Lead - Sydney
- Pharmacovigilance and Medical Information Associate - Sydney
- Senior Medical Communications Specialist - Sydney
- Warehouse & Medical Kit Assistant - Blacktown
Regulatory, Pharmacovigilance & QA (3)
- QA Specialist - Melbourne
- Senior Regulatory Affairs Associate - Sydney
- Pharmacovigilance and Medical Information Associate - Sydney
Executive Roles (1)
Other (9)
- Assistant Accoutant - Lane Cove West
- Inventory Team Supervisor - Melbourne
- Inventory Analyst - Sydney
- Warehouse Operator - Melbourne
- Inventory Analyst - Sydney
- Forklift Driver & Warehouse Assistant - Lane Cove
- Commercial Finance Analyst - Belrose
- Senior HR Business Partner - Melbourne
- Senior HRBP - Melbourne
Big win for 'high-potential' biotechs
Biointelect and venture-capital-as-a-service firm join forces to advance companies through the critical clinical development
20 April
GSK notches another RSV first
Company racks up its third win in this highly competitive space with its RSV vaccine the first to be added to the NIP for older Aussies
20 April
Two new drugs, first biosim ticked
New antibody-drug conjugate and a new antidote approved by the TGA alongside the first biosim of a Novartis cancer drug
20 April Approvals Action
No TGA action after patient deaths
ICYMI: Despite 8 overseas deaths and action from the FDA, the TGA is taking a routine approach plus the other popular stories this week
17 April Your Week in 5 Minutes
New hurdle for Novartis therapy
Telix is suing to invalidate the patent protecting Pluvicto to open the door to launching its competitor treatment
17 April
PBS listing delivers for rare cancer
The funding of a second-generation drug has given patients with this rare form of lung cancer another option
17 April
Hyped drug doubles sales forecast
This drug, recently considered by the PBAC, is living up to the hype overseas, with the company doubling its peak sales projections
16 April
Akesa appoints Country Manager
Melbourne-based pharmaceutical provider expands into Japan, appointing a senior industry executive to lead local operations
16 April
Ray of hope for 'bad juju' biotech
The FDA has thrown a lifeline to an Australian company after the discontinuation of its lead trial smashed its market capitalisation
16 April
Nine leaders vie for MA board seats
Voting will soon open to fill four vacancies on Medicines Australia's Board and the first round of campaign statements are here
16 April
Pfizer names local as Interim MD
Internal pick to step up as Interim Managing Director, after the surprise resignation of Anne Harris in January
15 April
Patient fury over pricing standoff
Company accused of "walking away from PBS pricing negotiations" leaving Aussie cancer patients $64K out-of-pocket
15 April
Aussie biotech inks global license
A Sydney-headquartered company is positioning itself to become a player in the $20 billion-a-year epigenetic therapy market
15 April
Lightning leadership change
A local CEO has been replaced within hours by a company stalwart, but no reason was given for the 'seamless transition'
15 April